---
title: "Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289098947.md"
description: "On June 8, 2026, at 22:01 CET in Mechelen, Belgium, Lakefront Bio therapeutics NV shared news of Dr. Eric Hedrick's appointment as Chief Medical Officer. This move aligns with the company's strategic shift after acquiring Ouro Medicines operational assets on June 4, 2026. Dr. Hedrick, MD, will now report to CEO Henry Gosebruch and become a member of the Management Committee. Lakefront Bio therapeutics NV, listed on Euronext & NASDAQ as LKFT, continues to focus on growth and transformation in its leadership structure."
datetime: "2026-06-08T20:03:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289098947.md)
  - [en](https://longbridge.com/en/news/289098947.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289098947.md)
---

# Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer

On June 8, 2026, at 22:01 CET in Mechelen, Belgium, Lakefront Bio therapeutics NV shared news of Dr. Eric Hedrick's appointment as Chief Medical Officer. This move aligns with the company's strategic shift after acquiring Ouro Medicines operational assets on June 4, 2026. Dr. Hedrick, MD, will now report to CEO Henry Gosebruch and become a member of the Management Committee. Lakefront Bio therapeutics NV, listed on Euronext & NASDAQ as LKFT, continues to focus on growth and transformation in its leadership structure.

### Related Stocks

- [LKFT.US](https://longbridge.com/en/quote/LKFT.US.md)

## Related News & Research

- [Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline | GILD Stock News](https://longbridge.com/en/news/288769642.md)
- [RBC Capital Sticks to Its Hold Rating for Lakefront Biotherapeutics (LKFT)](https://longbridge.com/en/news/286254871.md)
- [Belgium's Galapagos Q1 revenue falls 91% but returns to profit](https://longbridge.com/en/news/285430142.md)